Newer insights into the management of interstitial lung disease in systemic sclerosis

Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now the leading cause of death in SSc patients, largely from progressive respiratory failure or advanced pulmonary hypertension. Despite significant advances in our understanding of the epidemiology and pa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Robert L Mango, Jay H Ryu, Ashima Makol
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2017-01-01
coleção:	Indian Journal of Rheumatology
Assuntos:	Antifibrotic treatment connective tissue diseases immunosuppressive agents interstitial lung disease interstitial lung diseases systemic sclerosis
Acesso em linha:	http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=194;epage=203;aulast=Mango
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!